Fig. 3.

Anti-leukemic activity of cabazitaxel and plicamycin. ALL cell lines were plated at 50,000 cells/well in a 96 well cell culture plate and treated with indicated concentrations of either cabazitaxel (A) or plicamycin (C). 72 h post-treatment the cell viability was measured as described in methods. IC₅₀ values were calculated from the concentration curves for cabazitaxel (B) and plicamycin (D) using the compusyn software. The data was represented as Mean ± SEM of a study performed in triplicates at least three independent times.